Bayer, the renowned pharmaceutical powerhouse from Germany, is implementing a tiered pricing strategy on a global scale to make medications more accessible. The CEO emphasizes the necessity of earning returns to justify research investments. As innovation ecosystems shift, particularly towards regions like China, Bayer is proactively adapting.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/foMhiNY
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Time has never been better for Pharma breakthroughs than today: Bayer executive Stefan Oelrich






0 comments:
Post a Comment